Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Engage Grants Program

University of British Columbia

$25,000.00

Development of carbon nanotubes for non-viral gene transfer

EF 2015-16

Résumé
Gene transfection, the introduction of nucleic acids into cells, enables genes to be delivered into the nucleus of the target cell. Currently, the efficacy of gene transfer reagents is highly variable and also dependents on the target cell type. Due to the innate ability of certain viruses to deliver their viral genomes into the cell they infect, viral particles encapsulating an exogenous gene have been developed for gene transfection. Virus-mediated gene transfection, however, depends greatly on cell type and also has the problem of pathogenicity and oncogenicity. One of the major limitations of current non-viral gene transfer procedures is the inability to transport the gene into the nucleus of the target cell. We have recently discovered a new nuclear entry mechanism used by baculoviruses, and we propose to graft proteins from this virus to carbon nanotubes; these proteins can then direct the nanotube to the nucleus of cells. These nanotubes will also be conjugated with DNA and used for gene transfer to the nucleus of tissue-cultured cells. This novel non-viral gene transfer methodology will have the advantage of working with any cell system. As a leader in developing reagents for life science research, STEMCELL Technology is interested in developing high efficiency transfection reagents that target a broad range of cell types and can be used extensively in biomedical research. This collaboration with STEMCELL offers a great opportunity to develop carbon nanotubes for non-viral gene transfer. In addition to the development of a new gene transfection technology for life science research, this project will have a significant impact on efforts to develop efficient and successful non-viral gene therapies.
Programme
Engage Grants Program
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
485100-2015
Name nom
Panté, Nelly
Department département
Zoology
Organization id
2
Institution établissement
University of British Columbia
Province en
British Columbia
Province fr
Colombie-Britannique
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2015
Competition year année de concours
2015
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1554
Committee name en
Pacific Internal Decision Committee
Committee name fr
Comité de décision interne pour le Pacifique
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
5100
Research subject group en
Cell biology
Research subject group fr
Biologie cellulaire
Research subject en
Cell biology
Research subject fr
Biologie cellulaire
Partie
1
Nb partie
1
Application title
Development of carbon nanotubes for non-viral gene transfer
Keyword
NSERC
Application summary
Gene transfection, the introduction of nucleic acids into cells, enables genes to be delivered into the nucleus of the target cell. Currently, the efficacy of gene transfer reagents is highly variable and also dependents on the target cell type. Due to the innate ability of certain viruses to deliver their viral genomes into the cell they infect, viral particles encapsulating an exogenous gene have been developed for gene transfection. Virus-mediated gene transfection, however, depends greatly on cell type and also has the problem of pathogenicity and oncogenicity. One of the major limitations of current non-viral gene transfer procedures is the inability to transport the gene into the nucleus of the target cell. We have recently discovered a new nuclear entry mechanism used by baculoviruses, and we propose to graft proteins from this virus to carbon nanotubes; these proteins can then direct the nanotube to the nucleus of cells. These nanotubes will also be conjugated with DNA and used for gene transfer to the nucleus of tissue-cultured cells. This novel non-viral gene transfer methodology will have the advantage of working with any cell system. As a leader in developing reagents for life science research, STEMCELL Technology is interested in developing high efficiency transfection reagents that target a broad range of cell types and can be used extensively in biomedical research. This collaboration with STEMCELL offers a great opportunity to develop carbon nanotubes for non-viral gene transfer. In addition to the development of a new gene transfection technology for life science research, this project will have a significant impact on efforts to develop efficient and successful non-viral gene therapies.